CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
3.005
-0.175 (-5.50%)
Jun 5, 2026, 3:56 PM EDT - Market open
CytomX Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +266.06% | Jun 4, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $6 | Buy | Initiates | $6 | +99.67% | May 19, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $12 | Buy | Reiterates | $12 | +299.33% | May 13, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $17 → $11 | Buy | Maintains | $17 → $11 | +266.06% | May 11, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 | Buy | Reiterates | $12 | +299.33% | May 8, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $15 | Buy | Maintains | $15 | +399.17% | May 8, 2026 |
| Barclays | Barclays | Buy Reiterates $16 | Buy | Reiterates | $16 | +432.45% | May 8, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +299.33% | Mar 20, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.